Friedreich's sign

From WikiMD's Medical Encyclopedia

Revision as of 04:04, 4 April 2025 by Prab (talk | contribs) (CSV import)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)


Friedreich's sign
Synonyms
Pronounce N/A
Specialty Cardiology
Symptoms Rapid collapse of the jugular venous pulse
Complications N/A
Onset N/A
Duration N/A
Types N/A
Causes Constrictive pericarditis
Risks N/A
Diagnosis Physical examination, Echocardiography
Differential diagnosis Tricuspid regurgitation, Right heart failure
Prevention N/A
Treatment Treatment of underlying cause, Pericardiectomy
Medication N/A
Prognosis Depends on underlying condition
Frequency Rare
Deaths N/A


Friedreich's sign is a clinical sign associated with diseases of the heart. It is named after the German physician Nikolaus Friedreich who first described it in the 19th century. Friedreich's sign is characterized by a sudden collapse of the jugular veins' pulse during the middle of diastole. This phenomenon is most commonly observed in patients suffering from constrictive pericarditis, a condition where the pericardium (the fibrous sac surrounding the heart) becomes thickened and restricts the heart's movement.

Etiology[edit]

Friedreich's sign is indicative of an underlying heart condition, most notably constrictive pericarditis. This condition leads to the impaired filling of the heart's ventricles due to the rigid pericardium. As a result, there is a rapid filling of the ventricles at the beginning of diastole, followed by a sudden halt in ventricular filling due to the constrictive pericardium. This abrupt stop in filling is reflected as a collapse in the jugular venous pulse.

Pathophysiology[edit]

The pathophysiology of Friedreich's sign involves the dynamics of blood flow into the heart chambers during the cardiac cycle. In a healthy individual, the jugular venous pulse represents the indirect measure of right atrial pressure, which, in turn, reflects the filling pressure and volume changes in the right ventricle. However, in conditions like constrictive pericarditis, the pericardial disease restricts the diastolic filling of the ventricles, leading to a characteristic pattern in the jugular venous pulse observed as Friedreich's sign.

Clinical Significance[edit]

Friedreich's sign is a valuable diagnostic clue in the physical examination of patients suspected of having constrictive pericarditis. Its presence, along with other clinical features and diagnostic tests, can help in the differentiation of constrictive pericarditis from other diseases that present with similar symptoms, such as restrictive cardiomyopathy.

Diagnosis[edit]

The diagnosis of conditions associated with Friedreich's sign involves a comprehensive clinical assessment, including a detailed patient history, physical examination, and specific diagnostic tests. Echocardiography, cardiac MRI, and CT scans are among the imaging modalities used to assess the pericardium's thickness and the heart's function. Cardiac catheterization may also be performed to measure the pressures within the heart chambers and to differentiate constrictive pericarditis from other conditions.

Treatment[edit]

The treatment of constrictive pericarditis, and thereby addressing Friedreich's sign, typically involves surgical intervention. Pericardiectomy, the surgical removal of the thickened pericardium, is often required to relieve the constriction and improve heart function. Medical therapy may also be used to manage symptoms before or after surgery, but it does not address the underlying pericardial constriction.

Conclusion[edit]

Friedreich's sign is a significant clinical observation that can aid in the diagnosis of constrictive pericarditis. Understanding its etiology, pathophysiology, and clinical significance is crucial for healthcare professionals in accurately diagnosing and managing patients with this condition.

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

W8MD's happy loser(weight)

Tired of being overweight?

Special offer:

Budget GLP-1 weight loss medications

  • Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
  • Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay

✔ Same-week appointments, evenings & weekends

Learn more:

Advertise on WikiMD


WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.